1 Nakamura K, Yanaka K, Ihara S, et al. Multiple

intracranial arterial stenoses around the circle of

Willis in association with Graves' disease: report of

two cases[J]. Neurosurgery, 2003, 53:1210-1214.

2 Hsu SW, Chaloupka JC, Fattal D. Rapidly progressive

f at a l bi hemi sphe r ic i n f a r c t ion s e cond a r y to

Moyamoya syndrome in association with Graves

thyrotoxicosis[J]. AJNR Am J Neuroradiol, 2006,

27:643-647.

3 Lee R, Sung K, Park YM, et al. A case of Moyamoya

disease in a girl with thyrotoxicosis[J]. Yonsei Med J,

2009, 50:594-598.

4 Tsai MH, Tan TY, Kuo YL, et al. Multiple intracranial

arterial stenoses in association with thyrotoxicosis:a

case report[J]. Acta Neurol Taiwan, 2006, 15:105-108.

5 陈彬, 宋田, 张玉梅, 等. Graves病合并颈内动脉狭窄1

例报道[J]. 中国卒中杂志, 2012, 7:642-645.

6 Cheon CK, Kim SY, Yoo JH. Two adolescent patients

with coexistent Graves' disease and Moyamoya disease

in Korea[J]. Korean J Pediatr, 2014, 57:287-291.

7 Endo H, Fujimura M, Niizuma K, et al. Efficacy of

revascularization surgery for moyamoya syndrome

associated with Graves' disease[J]. Neurol Med

Chir(Tokyo), 2010, 50:977-983.

8 Ohba S, Nakagawa T, Murakami H. Concurrent

Graves' disease and intracranial arterial stenosis/

occlusion: special considerations regarding the

state of thyroid function, etiology, and treatment[J].

Neurosurg Rev, 2011, 34:297-304,

9 Sasaki T, Nogawa S, Amano T. Co-morbidity of

moyamoya disease with Graves' disease. report of

three cases and a review of the literature[J]. Intern

Med, 2006, 45:649-653.

10 倪俊, 高山, 崔丽英, 等. 甲状腺功能亢进合并颅内

动脉狭窄七例临床分析[J]. 中华神经科杂志, 2006,

39:268-270.

11 Colleran KM, Ratliff DM, Burge MR. Potential

a s s o c i a t io n of t hy r ot ox i c o s i s wi t h v i t ami n

B a nd fol a t e def i c i e nc i e s , r e s u l t i ng i n r i sk

fo r hy p e r h omo c y s t e i n emi a a n d s u b s e q u e nt

thromboembolic events[J]. Endocr Pract, 2003, 9:290-

295.

12 Inaba M, Henmi Y, Kumeda Y, et al. Increased

stiffness in common carotid artery in hyperthyroid

Graves' disease patients[J]. Biomed Pharmacother,

2002, 56:241-246.

13 Malik S, Russman AN, Katramados AM, et al.

Moyamoya syndrome associated with Graves' disease:

a case report and review of the literature[J]. J Stroke

Cerebrovasc Dis, 2011, 20:528-536.

14 Suzuki S, Mitsuyama T, Horiba A, et al. Moyamoya

disease complicated by Graves' disease and type 2

diabetes mellitus: report of two cases[J]. Clin Neurol

Neurosurg, 2011, 113:325-329.

15 Li H, Zhang ZS, Dong ZN, et al. Increased thyroid

function and elevated thyroid autoantibodies in

pediatric patients with moyamoya disease:a casecontrol

study[J]. Stroke, 2011, 42:1138-1139.

16 Pa neg y r e s PK, Mor r i s JG, O'Ne i l l PJ, e t a l.

Moyamoya-like disease with inflammation[J]. Eur

Neurol, 1993, 33:260-263.

17 Tokimura H, Tajitsu K, Takashima H, et al. Familial

moyamoya disease associated with Graves' disease in

a mother and daughter. Two case reports[J]. Neurol

Med Chir, 2010, 50:668-674.

18 Guo DC, Papke CL, Tran-Fadulu V, et al. Mutations in

smooth muscle alpha-actin (ACTA2) cause coronary

artery disease, stroke, and Moyamoya disease, along

with thoracic aortic disease[J]. Am J Hum Genet,

2009, 84:617-627.

19 Ohba S, Nakagawa T, Murakami H. Concurrent

Graves' disease and intracranial arterial stenosis/

occlusion: special considerations regarding the

state of thyroid function, etiology, and treatment[J].

Neurosurg Rev, 2011, 34:297-304.

20 Wa n g KC, Ph i JH, Le e JY, e t a l . I n d i r e c t

revascularization surgery for moyamoya disease in

children and its special considerations[J]. Korean J

Pediatr, 2012, 55:408-413.

21 Te n d l e r BE, Sh o u k r i K, Ma l ch of f C, e t a l .

Concur rence of Graves' disease and dysplastic cerebral blood vessels of the moyamoya variety[J].

Thyroid, 1997, 7:625-629.

22 Diekman MJ, Harms MP, Endert E, et al. Endocrine

factors related to changes in tot al per ipheral

vascular resistance after treatment of thyrotoxic

and hypothyroid patients[J]. Eur J Endocrinol, 2001,

144:339-346.

23 Faber J, Wiinberg N, Schifter S, et al. Haemodynamic

changes following treatment of subclinical and overt

hyperthyroidism[J]. Eur J Endocrinol, 2001, 145:391-

396.

24 Li D, Yang W, Xian P, et al. Coexistence of moyamoya

and Graves' diseases: the clinical characteristics

and treatment effects of 21 Chinese patients[J]. Clin

Neurol Neurosurg, 2013, 115:1647-1652.

25 Shi Z, Zhang X, Chen Z, et al. Elevated thyroid

autoantibodies and intracranial stenosis in stroke at an

early age[J]. Int J Stroke, 2014, 9:735-740.

26 Shen AL, Ryu SJ, Lin SK. Concurrent moyamoya

disease and Graves' thyrotoxicosis: case report and

literature review[J]. Acta Neurol Taiwan, 2006,

15:114-119.

27 Im SH, Oh CW, Kwon OK, et al. Moyamoya disease

associated with Graves disease: special considerations

regarding clinical significance and management[J]. J

Neurosurg, 2005, 102:1013-1017.

28 Utku U, Asil T, Celik Y, et al. Reversible MR

angiographic findings in a patient with autoimmune

Graves disease[J]. AJNR Am J Neuroradiol, 2004,

25:1541-1543.

29 Matano F, Murai Y, Adachi K, et al. Pathophysiology

and management of intracranial arterial stenosis

a rou nd t he c i r cle of Wi l l i s a s so c i a t e d wit h

hyperthyroidism: case reports and literature review[J].

Neurosurg Rev, 2014, 37:347-356

30 Wei YC, Liu CH, Chang TY, et al. Coexisting diseases

of moyamoya vasculopathy[J]. J Stroke Cerebrovasc

Dis, 2014, 23:1344-1350.